Oxaliplatin: all 947 studies that test it
Page 5 of 10. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal CancerStatus unknownNCT04134897Phase 3
- Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal TypeActive, not recruitingNCT04127227Phase 2
- The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma.Status unknownNCT04065282Phase 2
- A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric CancerStatus unknownNCT04062058Phase 2
- Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant TumorsStatus unknownNCT04060472Phase 2/3
- Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell CarcinomaStatus unknownNCT04049344Phase 2
- Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCLCompletedNCT04022005Phase 2
- Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.Status unknownNCT04003792Phase 2
- SOX-based CRT for Esophageal Cancer.WithdrawnNCT03991104Phase 1/2
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
- Neoadjuvant Immunotherapy for Resectable Gastric CancerCompletedNCT03878472Phase 2
- A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ AdenocarcinomaCompletedNCT03852251Phase 1/2
- TNT to Increase the Clinical Complete Response Rate for Distal LARCActive, not recruitingNCT03840239Phase 2
- A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )Status unknownNCT03825328Phase 2
- Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCCStatus unknownNCT03812770Phase 2
- Lenalidomide, Rituximab, Gemcitabine, Oxaliplatin and Dexamethasone in Relapse and Refractory DLBCLStatus unknownNCT03795571Phase 1
- PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT03791905Phase 2
- A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric CancerStatus unknownNCT03788226Phase 3
- Apatinib Combined With POF for Second-line Treatment of Gastric AdenocarcinomaStatus unknownNCT03788174Phase 2
- FOLFIRINOX for 2nd-line Treatment of BTCCompletedNCT03778593Phase 2
- Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric CancerActive, not recruitingNCT03764553Phase 2
- Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal CancerStatus unknownNCT03729687Phase 2
- Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACEWithdrawnNCT03722498Phase 2
- Study of the Combination of Apatinib and POFStatus unknownNCT03707639Phase 2
- Compare Neoadjuvant DOS Combined With Toripalimab Versus SOX Combined With Toripalimab in Locally Advanced Gastric AdenocarcinomaActive, not recruitingNCT03691454Phase 2/3
- Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric CancerCompletedNCT03647969Phase 2
- SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal CancerTerminatedNCT03645876Phase 2
- Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer PatientsStatus unknownNCT03626922Phase 1
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesStatus unknownNCT03607643Phase 1/2
- mFLOT Chemotherapy as First-line Treatment in GCCompletedNCT03606928Phase 1/2
- Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal CarcinomaStatus unknownNCT03585673Phase 2
- SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCCCompletedNCT03578874Phase 2
- QUILT-3.088: NANT Pancreatic Cancer VaccineWithdrawnNCT03563144Phase 2
- A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLMCompletedNCT03493061Phase 2
- First-line Therapy in Metastatic PDACStatus unknownNCT03487016Phase 2
- Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTCCompletedNCT03478488Phase 3
- HAIC of FOLFOX vs. HAIC of OXA for Advanced HCCStatus unknownNCT03468231Phase 3
- mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First LineCompletedNCT03464968Phase 2
- Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)Active, not recruitingNCT03448835Phase 2
- A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold SensitivityTerminatedNCT03427021Early Phase 1
- Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT03406299Phase 2
- The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic CancerStatus unknownNCT03403101Phase 2
- XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)CompletedNCT03399110Phase 3
- Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell LymphomaActive, not recruitingNCT03321643Phase 1
- S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic CancerStatus unknownNCT03316326Phase 2
- Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CAWithdrawnNCT03307941Phase 1/2
- Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive CancersTerminatedNCT03294252Phase 1/2
- Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine CarcinomaStatus unknownNCT03279614Phase 2
- Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric CancerStatus unknownNCT03263741Phase 2
- LEAn Body Mass Normalization of OXaliplatin Based ChemotherapyActive, not recruitingNCT03255434Phase 2
- Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRCCompletedNCT03253133Phase 1
- Phase I Study of the Combination of Apatinib and POFStatus unknownNCT03244774Phase 1
- QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) TherapyWithdrawnNCT03197584Phase 1/2
- Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric CancerStatus unknownNCT03192735Phase 2
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal CarcinomatosisActive, not recruitingNCT03172416Phase 1
- QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLWithdrawnNCT03169790Phase 1/2
- QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRCWithdrawnNCT03169777Phase 1/2
- QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsWithdrawnNCT03169738Phase 1/2
- A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic CancerStatus unknownNCT03167112Phase 2
- Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy NetworkCompletedNCT03164655Phase 2
- Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary CancersCompletedNCT03162510Phase 1
- Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal CancerTerminatedNCT03153280Phase 1
- Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal CancerCompletedNCT03146377Phase 2
- Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLMStatus unknownNCT03125161Phase 3
- Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric CancerCompletedNCT03121807Not applicable
- Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGCStatus unknownNCT03061058Phase 3
- Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.Status unknownNCT03042000Not applicable
- Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal CancerStatus unknownNCT03038217Phase 3
- Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' TreatmentStatus unknownNCT03028155Phase 3
- Paediatric Hepatic International Tumour TrialActive, not recruitingNCT03017326Phase 3
- The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric CancerStatus unknownNCT03007446Phase 2
- Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-FluorouracilStatus unknownNCT02987699Phase 2
- Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer PatientsCompletedNCT02980510Phase 2
- Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric CancerStatus unknownNCT02949258Phase 2
- Multicentric Randomised Trial for Resectable Gastric CancerActive, not recruitingNCT02931890Phase 2
- Nordic Pancreatic Cancer Trial (NorPACT) - 1Active, not recruitingNCT02919787Phase 2/3
- PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early StageStatus unknownNCT02918747Phase 2
- Radiochemotherapy in Elderly Patients With Oesophagus CancerCompletedNCT02879227Phase 2
- SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal CancerStatus unknownNCT02870153Phase 2
- Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric CancerTerminatedNCT02867839Phase 3
- Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal CancerCompletedNCT02848443Phase 1
- Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric CancerStatus unknownNCT02845986Phase 2
- POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGCCompletedNCT02845908Phase 2
- Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRICompletedNCT02833753Phase 1
- Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell LymphomaStatus unknownNCT02767674Phase 3
- Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.Status unknownNCT02745561Phase 2
- Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric CancerTerminatedNCT02720926Phase 1
- Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02716766Phase 2
- Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal CancerStatus unknownNCT02688023Phase 2
- Trial of Tolcapone With Oxaliplatin for NeuroblastomaTerminatedNCT02630043Phase 1
- Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic CancerCompletedNCT02620800Phase 1
- CCRT for Esophageal Cancer.CompletedNCT02607982Phase 2
- The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal ChemoradiotherapyStatus unknownNCT02604615Phase 3
- FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer (OPTICAL)Active, not recruitingNCT02572141Phase 3
- A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric CancerCompletedNCT02560974Phase 3
- Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic CancerCompletedNCT02558868Phase 2
- Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACEStatus unknownNCT02557503Phase 4
- Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver MetastasesStatus unknownNCT02557490Phase 4
- Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic CholangiocarcinomaStatus unknownNCT02548195Phase 3
- A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaCompletedNCT02539537Phase 3